Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer

Author:

D'Andrea David1ORCID,Black Peter C.2,Zargar Homayoun23,Dinney Colin P.4,Soria Francesco5,Cookson Michael S.6,Montgomery Jeffrey S.7,Kassouf Wassim8,Dall'Era Marc A.9,Sridhar Srikala S.10,McGrath John S.11,Wright Jonathan L.12,Thorpe Andrew C.13,Holzbeierlein Jeff M.14,Carrión Diego M.15,Di Trapani Ettore16,Bivalacqua Trinity J.17,North Scott1819,Barocas Daniel A.20,Lotan Yair21,Grivas Petros2223,Stephenson Andrew J.4,van Rhijn Bas W.24,Daneshmand Siamak25,Spiess Philippe E.26,Shariat Shahrokh F.121272829,

Affiliation:

1. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

2. Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

3. Department of Urology, Western Health, Melbourne, Australia

4. Department of Urology, MD Anderson Cancer Center, Houston, Texas

5. Department of Urology, Molinette Hospital, University of Turin, Turin, Italy

6. Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

7. Department of Urology, University of Michigan Health System, Ann Arbor, Michigan

8. Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada

9. Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, California

10. Princess Margaret Hospital, Toronto, Ontario, Canada

11. Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK

12. Department of Urology, University of Washington, Seattle, Washington

13. Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK

14. Department of Urology, University of Kansas Medical Center, Kansas City, Kansas

15. Department of Urology, Louisiana Paz University Hospital, Madrid, Spain

16. Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy

17. Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland

18. Cross Cancer Institute, Edmonton, Alberta, Canada

19. Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

20. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee

21. Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas

22. Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington

23. Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

24. Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

25. USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, California

26. Department of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

27. Departments of Urology, Weill Cornell Medical College, New York, New York

28. Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic

29. Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3